Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$186M Sell
1,240,878
-278,510
-18% -$41.4M 0.33% 51
2015
Q4
$248M Buy
1,519,388
+22,207
+1% +$3.49M 0.43% 30
2015
Q3
$207M Sell
1,497,181
-206,581
-12% -$32.6M 0.39% 47
2015
Q2
$262M Buy
1,703,762
+184,690
+12% +$29.6M 0.42% 33
2015
Q1
$243M Sell
1,519,072
-124,880
-8% -$19.7M 0.45% 30
2014
Q4
$264M Buy
1,643,952
+205,532
+14% +$32M 0.46% 25
2014
Q3
$202M Buy
1,438,420
+120,806
+9% +$15.8M 0.36% 50
2014
Q2
$169M Buy
1,317,614
+57,548
+5% +$6.66M 0.29% 73
2014
Q1
$142M Buy
1,260,066
+440,443
+54% +$53.4M 0.25% 89
2013
Q4
$97.6M Buy
819,623
+122,443
+18% +$13.9M 0.18% 130
2013
Q3
$78M Sell
697,180
-309,298
-31% -$33.5M 0.14% 164
2013
Q2
$99.3M Buy
+1,006,478
New +$104M 0.18% 126

Other funds holding AMGN

Russell Frank Company's AMGN Position: Q1 2016 in Review

Russell Frank Company reduced its Amgen (AMGN) stake by 18% in Q1 2016, selling an estimated $41.4M and leaving 1,240,878 shares worth $186M. The position accounts for 0.33% of the portfolio, ranked #51.

Russell Frank Company first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $264M in Q4 2014. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Russell Frank Company held 1,240,878 shares of Amgen worth $186M as of Q1 2016.
  • Russell Frank Company sold 278,510 Amgen shares in Q1 2016, an estimated $41.4M.
  • Amgen made up 0.33% of Russell Frank Company's portfolio in Q1 2016, its #51 holding.
  • Russell Frank Company first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
  • Russell Frank Company's Amgen position peaked at $264M in Q4 2014.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.